Market revenue in 2023 | USD 22.7 million |
Market revenue in 2030 | USD 29.3 million |
Growth rate | 3.7% (CAGR from 2023 to 2030) |
Largest segment | Indirect immunofluorescence |
Fastest growing segment | Indirect Immunofluorescence |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Indirect Immunofluorescence, Direct Immunofluorescence |
Key market players worldwide | Thermo Fisher Scientific Inc, Inova Diagnostics, Bio-Rad Laboratories Inc, Abcam PLC, PerkinElmer, Merck KGaA, Cell Signaling Technology, Sino Biological, Danaher Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to immunofluorescence assay market will help companies and investors design strategic landscapes.
Indirect immunofluorescence was the largest segment with a revenue share of 66.08% in 2023. Horizon Databook has segmented the South Africa immunofluorescence assay market based on indirect immunofluorescence, direct immunofluorescence covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa immunofluorescence assay market, including forecasts for subscribers. This country databook contains high-level insights into South Africa immunofluorescence assay market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account